660 related articles for article (PubMed ID: 31730762)
1. Neural stem cell therapy for neurovascular injury in Alzheimer's disease.
Boese AC; Hamblin MH; Lee JP
Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
3. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
4. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
6. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán RM; Javadov S; Fossati S
Cells; 2021 Oct; 10(11):. PubMed ID: 34831125
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulants for Treatment of Alzheimer's Disease.
Grossmann K
J Alzheimers Dis; 2020; 77(4):1373-1382. PubMed ID: 32925057
[TBL] [Abstract][Full Text] [Related]
9. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
[TBL] [Abstract][Full Text] [Related]
12. Adult neurogenesis, neural stem cells and Alzheimer's disease: developments, limitations, problems and promises.
Taupin P
Curr Alzheimer Res; 2009 Dec; 6(6):461-70. PubMed ID: 19747153
[TBL] [Abstract][Full Text] [Related]
13. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.
Fisher RA; Miners JS; Love S
Brain Pathol; 2022 Nov; 32(6):e13061. PubMed ID: 35289012
[TBL] [Abstract][Full Text] [Related]
14. Neurovascular mechanisms of Alzheimer's neurodegeneration.
Zlokovic BV
Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
[TBL] [Abstract][Full Text] [Related]
15. The Molecular and Functional Changes of Neural Stem Cells in Alzheimer's Disease: Can They be Reinvigorated to Conduct Neurogenesis.
Abu-El-Rub E; Khasawneh RR; Almahasneh FA; Aloud BM; Zegallai HM
Curr Stem Cell Res Ther; 2023; 18(5):580-594. PubMed ID: 36045542
[TBL] [Abstract][Full Text] [Related]
16. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
17. Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.
Hossain MF; Uddin MS; Uddin GMS; Sumsuzzman DM; Islam MS; Barreto GE; Mathew B; Ashraf GM
Mol Neurobiol; 2019 Dec; 56(12):8255-8276. PubMed ID: 31209782
[TBL] [Abstract][Full Text] [Related]
18. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
[TBL] [Abstract][Full Text] [Related]
19. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
20. Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link.
Ramos-Cejudo J; Wisniewski T; Marmar C; Zetterberg H; Blennow K; de Leon MJ; Fossati S
EBioMedicine; 2018 Feb; 28():21-30. PubMed ID: 29396300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]